Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$499K Buy
4,149
+31
+0.8% +$3.58K 0.17% 125
2025
Q4
$434K Sell
4,118
-89
-2% -$8.36K 0.14% 127
2025
Q3
$353K Sell
4,207
-297
-7% -$24.5K 0.11% 132
2025
Q2
$357K Buy
4,504
+2
+0% +$159 0.13% 131
2025
Q1
$404K Buy
4,502
+2
+0% +$187 0.17% 116
2024
Q4
$448K Buy
4,500
+1
+0% +$103 0.18% 114
2024
Q3
$511K Buy
4,499
+11
+0.2% +$1.31K 0.22% 102
2024
Q2
$556K Hold
4,488
0.26% 95
2024
Q1
$580K Buy
4,488
+3
+0.1% +$370 0.27% 94
2023
Q4
$489K Buy
4,485
+416
+10% +$43.2K 0.27% 104
2023
Q3
$469K Hold
4,069
0.32% 93
2023
Q2
$469K Sell
4,069
-499
-11% -$56.7K 0.32% 93
2023
Q1
$486K Buy
4,568
+1
+0% +$108 0.29% 101
2022
Q4
$507K Buy
4,567
+300
+7% +$30.7K 0.29% 101
2022
Q3
$367K Buy
4,267
+1
+0% +$89 0.23% 110
2022
Q2
$389K Buy
4,266
+1
+0% +$89 0.23% 105
2022
Q1
$350K Sell
4,265
-25
-0.6% -$1.97K 0.18% 117
2021
Q4
$329K Buy
4,290
+211
+5% +$16.8K 0.17% 121
2021
Q3
$306K Buy
4,079
+420
+11% +$31.9K 0.16% 122
2021
Q2
$285K Sell
3,659
-149
-4% -$11.1K 0.14% 121
2021
Q1
$280K Buy
3,808
+165
+5% +$12.2K 0.13% 101
2020
Q4
$284K Hold
3,643
0.15% 94
2020
Q3
$288K Hold
3,643
0.21% 79
2020
Q2
$269K Buy
3,643
+632
+21% +$47.6K 0.19% 72
2020
Q1
$221K Hold
3,011
0.22% 66
2019
Q4
$261K Buy
3,011
+183
+6% +$15K 0.15% 68
2019
Q3
$227K Buy
+2,828
New +$227K 0.14% 67

Other funds holding MRK

X-Square Capital's MRK Position: Q1 2026 in Review

X-Square Capital increased its Merck (MRK) stake by 0.75% in Q1 2026, buying an estimated $3.58K and bringing the position to 4,149 shares worth $499K. The position accounts for 0.17% of the portfolio, ranked #125.

X-Square Capital first reported a position in MRK in Q3 2019 and has held it in 27 quarters since. The position peaked at $580K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • X-Square Capital held 4,149 shares of Merck worth $499K as of Q1 2026.
  • X-Square Capital bought 31 Merck shares in Q1 2026, an estimated $3.58K.
  • Merck made up 0.17% of X-Square Capital's portfolio in Q1 2026, its #125 holding.
  • X-Square Capital first reported a position in Merck in Q3 2019 and has held it in 27 quarters since.
  • X-Square Capital's Merck position peaked at $580K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on X-Square Capital's 13F filing for Q1 2026, filed 15 May 2026.